HK1203190A1 - Compounds for use in imaging, diagnosing and or treatment of diseases of the central nervous system - Google Patents

Compounds for use in imaging, diagnosing and or treatment of diseases of the central nervous system

Info

Publication number
HK1203190A1
HK1203190A1 HK15103757.0A HK15103757A HK1203190A1 HK 1203190 A1 HK1203190 A1 HK 1203190A1 HK 15103757 A HK15103757 A HK 15103757A HK 1203190 A1 HK1203190 A1 HK 1203190A1
Authority
HK
Hong Kong
Prior art keywords
diagnosing
diseases
imaging
compounds
treatment
Prior art date
Application number
HK15103757.0A
Other languages
English (en)
Chinese (zh)
Inventor
Andrea Thiele
Georg Kettschau
Tobias Heinrich
Lutz Lehmann
Christer Halldin
Sangram Nag
Andrea Varrone
Balazs Gulyas
Original Assignee
Piramal Imaging Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Piramal Imaging Sa filed Critical Piramal Imaging Sa
Publication of HK1203190A1 publication Critical patent/HK1203190A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001Acyclic or carbocyclic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/04Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups
    • C07C209/14Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of hydroxy groups or of etherified or esterified hydroxy groups
    • C07C209/16Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of hydroxy groups or of etherified or esterified hydroxy groups with formation of amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/29Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK15103757.0A 2010-10-22 2015-04-17 Compounds for use in imaging, diagnosing and or treatment of diseases of the central nervous system HK1203190A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10188559A EP2450332A1 (fr) 2010-10-22 2010-10-22 Composants à utiliser dans l'imagerie, le diagnostic et/ou le traitement des maladies du système nerveux central (F-D2-déprényle)

Publications (1)

Publication Number Publication Date
HK1203190A1 true HK1203190A1 (en) 2015-10-23

Family

ID=43760025

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15103757.0A HK1203190A1 (en) 2010-10-22 2015-04-17 Compounds for use in imaging, diagnosing and or treatment of diseases of the central nervous system

Country Status (18)

Country Link
US (1) US9314540B2 (fr)
EP (2) EP2450332A1 (fr)
JP (1) JP5964840B2 (fr)
KR (1) KR101852647B1 (fr)
CN (2) CN103443056A (fr)
AR (1) AR083519A1 (fr)
AU (1) AU2011317664A1 (fr)
BR (1) BR112013009861A2 (fr)
CA (1) CA2815401C (fr)
DK (1) DK2630104T3 (fr)
EA (1) EA023820B1 (fr)
HK (1) HK1203190A1 (fr)
IL (1) IL225855A0 (fr)
MX (1) MX340487B (fr)
NZ (1) NZ610736A (fr)
SG (1) SG189478A1 (fr)
TW (1) TW201225979A (fr)
WO (1) WO2012052409A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2053033A1 (fr) * 2007-10-26 2009-04-29 Bayer Schering Pharma AG Composants à utiliser dans l'imagerie, le diagnostic et/ou le traitement des maladies du système nerveux central ou des tumeurs
WO2015143019A2 (fr) * 2014-03-18 2015-09-24 Mayo Foundation For Medical Education And Research Technologies à f-18 gazeux
MX2016014615A (es) 2014-05-13 2017-03-06 Hoffmann La Roche Compuestos heterociclicos deuterados y su uso como agentes formadores de imagenes.
CN107445798B (zh) * 2016-06-01 2020-11-03 中国农业大学 一种α,α‐二氘代醇类化合物的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ329471A (en) * 1995-03-02 1999-10-28 Scherer Ltd R P Use of monoamide oxidase b inhibitors to treat parkinson's disease
EP1104174A4 (fr) * 1998-06-09 2006-08-02 Matsushita Electric Ind Co Ltd Codeur et decodeur d'images, verificateur de caracteres et support de donnees
EP2053033A1 (fr) 2007-10-26 2009-04-29 Bayer Schering Pharma AG Composants à utiliser dans l'imagerie, le diagnostic et/ou le traitement des maladies du système nerveux central ou des tumeurs
WO2010121719A1 (fr) 2009-04-23 2010-10-28 Bayer Schering Pharma Aktiengesellschaft Nouvelles molécules précurseurs pour des traceurs pet marqués par f-18

Also Published As

Publication number Publication date
EA201300479A1 (ru) 2013-10-30
JP5964840B2 (ja) 2016-08-03
CA2815401C (fr) 2019-04-09
EA023820B1 (ru) 2016-07-29
KR20140023870A (ko) 2014-02-27
NZ610736A (en) 2014-11-28
AR083519A1 (es) 2013-03-06
MX2013004457A (es) 2013-09-16
TW201225979A (en) 2012-07-01
CN104478735A (zh) 2015-04-01
EP2450332A1 (fr) 2012-05-09
EP2630104A1 (fr) 2013-08-28
CN104478735B (zh) 2017-05-31
US20130336890A1 (en) 2013-12-19
CA2815401A1 (fr) 2012-04-26
DK2630104T3 (en) 2018-07-16
US9314540B2 (en) 2016-04-19
EP2630104B1 (fr) 2018-04-04
WO2012052409A1 (fr) 2012-04-26
SG189478A1 (en) 2013-05-31
AU2011317664A1 (en) 2013-05-23
CN103443056A (zh) 2013-12-11
MX340487B (es) 2016-07-11
BR112013009861A2 (pt) 2019-09-24
KR101852647B1 (ko) 2018-04-26
JP2014502257A (ja) 2014-01-30
IL225855A0 (en) 2013-07-31

Similar Documents

Publication Publication Date Title
IL265774B (en) Diagnosis, prevention and treatment of joint diseases
IL222251A0 (en) Methods, system and apparatus for the detection, diagnosis and treatment of biological rhythm disorders
ZA201304638B (en) Composition for use in the prevention and /or treatment of skin condition and skin diseases.
EP2651496A4 (fr) Dispositifs, systèmes et méthodes pour le traitement de troubles médicaux
HK1178074A1 (en) Compositions and methods for the diagnosis and treatment of tumor
HK1184370A1 (zh) 用於治療疼痛的藥物組合
IL216967B (en) The history of 17-hydroxy-17-pentafluoroethyl-astra-9,4 (10)-diene-11-aryl and their use for the treatment of diseases
HK1145316A1 (zh) 用於中樞神經系統疾病或腫瘤的成像、診斷和/或治療的化合物
HUS2000020I1 (hu) Ciklezonid a légúti betegségek kezelésére lovaknál
EP2629795A4 (fr) Anticorps humains et leurs utilisations diagnostiques et thérapeutiques dans le traitement de troubles neurologiques
IL260078B (en) Therapy used to treat Gaucher disease
HK1173181A1 (en) Medicament and agent for treating and diagnosing immune disorders and their use
HK1203190A1 (en) Compounds for use in imaging, diagnosing and or treatment of diseases of the central nervous system
PL392436A1 (pl) Pochodne arylosulfonamidów do leczenia chorób odśrodkowego układu nerwowego
EP2361317A4 (fr) Utilisation de eif3m pour le diagnostic et le traitement du cancer
HK1214771A1 (zh) 用於治療皮膚病的製劑
ZA201306759B (en) Compounds for use in imaging,diagnosing and/or treatment of diseases of the central nervous system
EP2588866A4 (fr) Diagnostic et traitement de tumeurs cérébrales
HK1188565A1 (en) Diarylpyridazinone derivatives, preparation thereof, and use thereof for the treatment of humans
GB201018325D0 (en) Treatment for dupuytren's disease
EP2531186A4 (fr) Traitement des affections cutanées
AU2010902958A0 (en) Diagnosis and treatment of brain tumors
GB2477743A9 (en) Respiratory disease treatment.